Although both studies reported impaired glucose tolerance in Hnf4A deficient mice, along with defects in GSIS, neither study observed sustained hypoinsulinemic hyperglycemia – the defining symptom that brings MODY1 patients to the clinic. Here, HNF4A is linked to Hyperglycemia.